DENDREON CORP (DNDN) 28.01 -$0.04 (-0.14%) 09:27PM (15 mins delay)

Dendreon Corp is the type of investment that will only grow with new discoveries. This discovery door has been opened with the FDA approval of a cancer drug that will drop the number of deaths due to...

Read complete stock pick on DNDN

1) FDA approval: DNDN's Provenge met and exceeded all FDA-stated requirements for approval. The most recent trial results constitute conclusive proof that Provenge works, and the FDA WILL approve the...

Read complete stock pick on DNDN

DNDN is an innovative company that developed Provenge to combat prostate cancer. It has been voted 17-0 as safe, but 13-4 to meet the guidelines of congressional approval. The 4 no votes had conflict...

Read complete stock pick on DNDN

alright, so we have another pharmacy stock. right off the bad its gonna be volatile. they have this drug called provenge that is supposed to help people with prostate. did well in the lab, did well on...

Read complete stock pick on DNDN

Dendreon Corporation is developing new ways and medicines against prostate cancer and other forms of cancer. With these new and effective medicines, the stock will no doubt increase. DNDN is supposedly...

Read complete stock pick on DNDN